Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors
Cancer Cell2016Vol. 29(3), pp. 255–269
Citations Over TimeTop 1% of 2016 papers
Shom Goel, Qi Wang, April C. Watt, Sara M. Tolaney, Deborah Dillon, Wěi Li, Susanne Ramm, Adam C. Palmer, Haluk Yuzugullu, Vinay Varadan, David Tuck, Lyndsay N. Harris, Kwok‐Kin Wong, X. Shirley Liu, Piotr Siciński, Eric P. Winer, Ian E. Krop, Jean J. Zhao
Related Papers
- → AMPK-dependent phosphorylation of the GATOR2 component WDR24 suppresses glucose-mediated mTORC1 activation(2023)38 cited
- → Regulation of Mammalian Target of Rapamycin Complex 1 by Bcl-2 and Bcl-XL Proteins(2013)17 cited
- → Hayatine inhibits amino acid-induced mTORC1 activation as a novel mTOR-Rag A/C interaction disruptor(2021)2 cited
- → Environmental Sensing by mTORC1(2021)
- → ИСПОЛЬЗОВAНИЕ ПОТЕНЦИAЛA СОЦИAЛЬНЫХ ПAРТНЕРОВ В ПОДГОТОВКЕ БУДУЩИХ ПЕДAГОГОВ(2024)